+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2016-04-26Number of Pages: 70

Needle Free Drug Delivery Devices Market (Jet Injectors and Competing Needle-Free Technologies; Vaccine Delivery, Pain Management, Insulin Delivery, Pediatric Injections, and Other) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

This report on the needle free drug delivery devices market analyzes the current and future scenario of the global market. Large number of chronic pain and diabetes sufferers is increasing the usage of needle free drug delivery devices. Less pain and consistency in drug delivery are the major drivers of the global needle free drug delivery devices market.

The needle free drug delivery devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global needle free drug delivery devices market.

Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment has been further divided into novel needle technology, inhaler technology, and transdermal patch technology. Novel needle technology includes micro-needle and pen needle. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year.

Based on application, the needle free drug delivery devices market has been segmented into five major categories: vaccine delivery, pain management, insulin delivery, pediatric injections, and others. Other applications of needle free drug delivery devices include angina, hypertension, and other medical conditions. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

Geographically, the global needle free drug delivery devices market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.

The report also profiles major players in the global needle free drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Zogenix, Inc., 3M Health Care, Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc.

The global needle free drug delivery devices market has been segmented as follows:

  • Global Needle Free Drug Delivery Devices Market Revenue, by Technology, (US$ Mn), 2013–2023
    • Jet Injectors
    • Competing Needle-free Technologies
      • Novel Needle Technology
      • Inhaler Technology
      • Transdermal Patch Technology
  • Global Needle Free Drug Delivery Devices Market Revenue, by Application, (US$ Mn), 2013–2023
    • Vaccine Delivery
    • Pain Management
    • Insulin Delivery
    • Pediatric Injections
    • Other Applications
  • Global Needle Free Drug Delivery Devices Market Revenue, By Geography, (US$ Mn), 2013–2023
    • Overview
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • Rest of Europe
    • Asia Pacific
      • Japan
      • China
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • Rest of Middle East & Africa

Table of Content

1. Preface
     1.1. Report Description
     1.2. Market Segmentation
     1.3. Research Methodology

2. Executive Summary
     2.1. Global Needle Free Drug Delivery Devices Market Share, by Geography, 2014–2023 (US$ Mn)
     2.2. Global Needle Free Drug Delivery Devices Market, by Technology and Application, 2014 (US$ Mn)
     2.3. Needle Free Drug Delivery Devices: Market Snapshot

3. Needle Free Drug Delivery Devices Market - Industry Analysis
     3.1. Introduction
     3.2. Market Dynamics
           3.2.1. Drivers
           3.2.2. Restraints
           3.2.3. Opportunities
     3.3. Porter’s Five Forces Analysis
     3.4. Market Attractiveness Analysis - Needle Free Drug Delivery Devices Market, by Geography (2014) (%) 
     3.5. Competitive Landscape - Needle Free Drug Delivery Devices Market, by Key Players, 2014 (%)

4. Market Segmentation - By Technology 
     4.1. Introduction 
     4.2. Global Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023 (US$ Mn)
     4.3. Global Jet Injectors Market Revenue, 2013–2023 (US$ Mn)
     4.4. Global Competing Needle Free Technology Market Revenue, 2013–2023 (US$ Mn)
           4.4.1. Global Novel Needle Technology Market Revenue, 2013–2023 (US$ Mn)
           4.4.2. Global Inhaler Technology Market Revenue, 2013–2023 (US$ Mn)
           4.4.3. Global Transdermal Patch Technology Market Revenue, 2013–2023 (US$ Mn)

5. Market Segmentation - By Application 
     5.1. Introduction 
     5.2. Global Needle Free Drug Delivery Devices Market Revenue, by Application, 2013–2023 (US$ Mn)
     5.3. Global Vaccine Delivery Market Revenue, 2013–2023 (US$ Mn)
     5.4. Global Pain Management Market Revenue, 2013–2023 (US$ Mn)
     5.5. Global Insulin Delivery for Diabetes Market Revenue, 2013–2023 (US$ Mn)
     5.6. Global Pediatric Injections Market Revenue, 2013–2023 (US$ Mn)
     5.7. Global Other Applications Market Revenue, 2013–2023 (US$ Mn)

6. Market Segmentation - By Geography
     6.1. Introduction
     6.2. Global Needle Free Drug Delivery Devices Market Revenue, by Geography, 2013–2023 (US$ Mn)
     6.3. North America Needle Free Drug Delivery Devices Market Revenue, 2013–2023 (US$ Mn)
     6.4. Europe Needle Free Drug Delivery Devices Market Revenue, 2013–2023 (US$ Mn)
     6.5. Asia Pacific Needle Free Drug Delivery Devices Market Revenue, 2013–2023 (US$ Mn)
     6.6. Latin America Needle Free Drug Delivery Devices Market Revenue, 2013–2023 (US$ Mn)
     6.7. Middle East & Africa Needle Free Drug Delivery Devices Market Revenue, 2013–2023 (US$ Mn)

7. Recommendations

8. Company Profiles
     8.1. 3M
     8.2. Antares Pharma, Inc.
     8.3. Glide Pharmaceutical Technologies Ltd.
     8.4. Injex Pharma AG
     8.5. Pharmajet, Inc.
     8.6. Zogenix, Inc.

List of Figures

FIG. 1 Needle Free Drug Delivery: Market Segmentation
FIG. 2 Global Needle-free Drug Delivery Devices Market Share, by Geography, 2014
FIG. 3 Global Needle-free Drug Delivery Devices Market Share, by Geography, 2023
FIG. 4 Global Needle-free Drug Delivery Devices Market, by Geography, 2014, Value (%)
FIG. 5 Global Needle-free Drug Delivery Devices Market, by Key Players, 2014 (%)
FIG. 6 Global Jet Injectors Market Revenue, 2013–2023, (US$ Mn)
FIG. 7 Global Novel Needle Technology Market Revenue, 2013–2023, (US$ Mn)
FIG. 8 Global Inhaler Technology Market Revenue, 2013–2023, (US$ Mn)
FIG. 9 Global Transdermal Patch Technology Market Revenue, 2013–2023, (US$ Mn)
FIG. 10 Global Vaccine Delivery Market Revenue, 2013–2023, (US$ Mn)
FIG. 11 Global Pain Management Market Revenue, 2013–2023, (US$ Mn)
FIG. 12 Global Insulin Delivery for Diabetes Market Revenue, 2013–2023, (US$ Mn)
FIG. 13 Global Pediatric Injections Market Revenue, 2013–2023, (US$ Mn)
FIG. 14 Global Other Applications Market Revenue, 2013–2023, (US$ Mn)
FIG. 15 3 M Health Care: Financial Overview: 2012–2014 (US$ Mn)
FIG. 16 Antares Pharma, Inc.: Financial Overview: 2012–2014 (US$ Mn)
FIG. 17 Zogenix, Inc.: Financial Overview: 2012–2014 (US$ Mn)

List of Tables

TABLE 1: Needle-free Drug Delivery Devices: Market Snapshot
TABLE 2: Global Needle-Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023, (US$ Mn)
TABLE 3: Global Competing Needle Free Technology Market Revenue, by Type, 2013–2023, (US$ Mn)
TABLE 4: Global Needle Free Drug Delivery Devices Market Revenue, by Application, 2013–2023, (US$ Mn)
TABLE 5: Global Needle-Free Drug Delivery Devices Market Revenue, by Geography, 2013–2023 (US$ Mn)
TABLE 6: North America Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023 (US$ Mn)
TABLE 7: North America Needle Free Drug Delivery Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
TABLE 8: Europe Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023 (US$ Mn)
TABLE 9: Europe Needle Free Drug Delivery Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
TABLE 10: Asia Pacific Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023 (US$ Mn)
TABLE 11: Asia Pacific Needle Free Drug Delivery Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
TABLE 12: Latin America Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023 (US$ Mn)
TABLE 13: Latin America Needle Free Drug Delivery Devices Market Revenue, by Country, 2013–2023 (US$ Mn)
TABLE 14: Middle East and Africa Needle Free Drug Delivery Devices Market Revenue, by Technology, 2013–2023 (US$ Mn)
TABLE 15: Middle East & Africa Needle Free Drug Delivery Devices Market Revenue, by Country, 2013–2023 (US$ Mn)

Drug delivery plays a vital role in human health care. Needle free drug delivery devices are novel drug delivery devices to inject drugs into a patients’ body without invading the skin tissue with a conventional needle. The first needle free injection systems were developed in the 1940s and 1950s for the U.S. soldiers. These are now poised to become mainstream. Lesser pain and stress; elimination of the need for needle disposal, consistency in drug delivery, and zero risk of broken needles are the major advantages of needle free drug delivery devices over conventional drug delivery devices. Hence, the global needle free drug delivery devices market is likely to witness strong growth during the forecast period from 2015–2023. However, high start-up cost and requirement for training and maintenance are some of restraints of the market. 
 
The global needle free drug delivery devices market has been segmented based on technology and application of devices. Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment accounted for the highest share of the market in 2014. However, the jet injectors segment is expected to grow at a higher rate during the forecast period due to rising incidence of needlestick injuries. Additionally, continuous evolution in jet injector technology is anticipated to drive the market during the forecast period. Novel needle technology, inhaler technology, and transdermal patch technology are included in the competing needle-free technologies segment. The novel needle technology sub-segment accounted for the highest share of the competing needle-free technologies segment in 2014. However, the transdermal patch technology segment is likely to witness highest growth rate during the forecast period. Controlled drug delivery and elimination of pre-systemic metabolism are the major factors driving the transdermal patch technology segment. Based on application, the market has been segmented into vaccine delivery, pain management, insulin delivery, pediatric injections, and others. The insulin delivery segment accounted for the largest share of the market in 2014. The segment is expected to maintain its leadership position during the forecast period. However, the pediatric injections segment is likely to grow at the highest rate during the forecast period due to public awareness and government initiatives for pediatric vaccination.

Geographically, the needle free drug delivery devices market has been classified into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the global needle free drug delivery devices market in 2014. The region is expected to maintain its market position during the forecast period from 2015 to 2023. This is due to high awareness about novel drug delivery systems, presence of major key players, and high investment in research and development activities. However, Asia Pacific is likely to witness the highest CAGR during the forecast period due to increase in health care infrastructure and distribution strategies adopted by the market players. Europe accounted for the second largest share of the market in 2014 due to high geriatric population that would increase demand for convenient drug delivery options. Latin America is likely to record the second highest growth during the forecast period due to rising prevalence of chronic diseases, improving health care scenario, and growing investment by leading players.

The needle free drug delivery devices market is consolidated. However, Zogenix, Inc., 3M, and Antares Pharma, Inc. dominated the global market in 2014. Other players operating in the market are Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc. Partnerships and novel distribution strategies of the leading companies would help boost market growth during the forecast period. In March 2013, Zogenix, Inc. and Battelle extended their co-marketing partnership for the DosePro needle-free drug delivery system through March 29, 2014. 

needle-free-drug-delivery-devices-market

 


A complete brochure for this research is available for download.

Interact with our pool of experienced analysts for any report related queries